Sign in Pull a receipt

AIDX

20/20 Biolabs, Inc.

Healthcare · Medical Devices

$282.69 sample

-1.23 (-0.43%) 1D

Market cap

$786.1B

Price as of

2026-10-29

Latest filing

8-K · 2026-10-16

Alerts

8

Price$282.69 +5.18% 3M daily closessample

286.17259.75

2026-08-032026-08-252026-09-162026-10-072026-10-29

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 26INSInsider sell: General Counsel
Oct 16SEC8-K filed: material event
Oct 09INSInsider sell: 10% owner
Sep 30INSInsider buy: Chief Financial Officer
Sep 23INSInsider buy: EVP, Operations
Sep 17INSInsider sell: EVP, Operations
Sep 10INSInsider buy: Chief Executive Officer
Sep 01INSInsider buy: Chief Financial Officer

Sign up to see the real AIDX record →

Company facts

SEC EDGAR registration

Name: 20/20 Biolabs, Inc.
Sector: Healthcare
Industry: Medical Devices
Smart-money score: -7sample, -100 to +100
Reporting currency: USD

Who is positioning in AIDX

sample

Insiders: 6 insider transactions over 90 days, net selling, $206.7M
Congress: 4 members traded over 90 days
Institutions · 13F: 9 funds hold $7.7B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$52.7B +16.1% y/y

Q4 2024Q3 2026

Inventory$30.2B +9.8% y/y

Q4 2024Q3 2026

Accounts receivable$23.1B +10.8% y/y

Q4 2024Q3 2026

Total debt$60.5B +15.1% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $322.8B +11.2% 3M
Sample peer B: $500.3B +10.5% 3M
Sample peer C: $580.9B +0.5% 3M
Sample peer D: $487.0B +9.3% 3M
Sample peer E: $390.4B +14.1% 3M